Treatment of 149 cases of large-volume benign prostatic hyperplasia with blue laser vaporization
10.12483/j.issn.1009-8291.2026.05.008
- VernacularTitle:蓝激光汽化术治疗大体积良性前列腺增生149例（附视频）
- Author:
Haifeng CHENG
1
;
Chao WANG
1
;
Quan DU
1
;
Guoxiong LIU
1
;
Zhenwei FAN
1
;
Xiaoliang FU
1
;
Nan LI
1
;
Wanglong YUN
2
;
Xiaofeng XU
1
Author Information
1. Department of Urology, Xianyang Central Hospital, Xianyang 712000, China
2. Department of Anesthesiology and Operating, Xianyang Central Hospital, Xianyang 712000, China
- Publication Type:Journal Article
- Keywords:
200 W 450 nm semiconductor blue laser;
benign prostatic hyperplasia;
transurethral prostate blue laser vaporization;
urinary control function;
lower urinary tract symptom
- From:
Journal of Modern Urology
2026;31(5):443-445
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy and safety of blue laser vaporization in the treatment of large-volume (＞80 mL) benign prostatic hyperplasia (BPH). Methods A retrospective analysis was conducted on the clinical data of 149 BPH patients with prostate volume＞80 mL who underwent blue laser vaporization at our hospital during Aug. 2023 and Aug. 2025. The 1-month postoperative maximum urinary flow rate (Qmax) and international prostate symptom score (IPSS), operation time, postoperative hemoglobin drop, bladder irrigation volume, catheter indwelling time, and incidence of postoperative complications were recorded and analyzed. Results All operations were successfully completed, without conversion to other approaches. The operation time was (41.47±11.05) minutes, postoperative hemoglobin drop (2.78±1.19) g/L, bladder irrigation volume (9.97±1.49) bags, and catheter indwelling time (3.30±1.85) days. One month after surgery, the Qmax was significantly higher than the preoperative value [(20.19±3.39) mL/s vs. (2.39±2.17) mL/s], while the IPSS was significantly lower [(4.46±0.87) vs. (27.69±2.06)], with statistically significant differences (P＜0.001). Postoperative complications included 1 case of incontinence (0.67%), 2 cases of urethral stricture/bladder neck contracture (1.34%), and 1 case of secondary bleeding (0.67%), all of which improved with symptomatic treatment. Conclusion Blue laser vaporization is effective for treating large-volume BPH, with advantages such as minimal bleeding risk, short operation time, fast recovery and safety.
